Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab

Detalles Bibliográficos
Autores principales: Brunner, P.M., Conrad, C., Vender, R., Grond, S., Schuster, C., Patel, H., Xu, W., Carrascosa Carrillo, J.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518506/
https://www.ncbi.nlm.nih.gov/pubmed/34076896
http://dx.doi.org/10.1111/bjd.20527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518506/
https://www.ncbi.nlm.nih.gov/pubmed/34076896
http://dx.doi.org/10.1111/bjd.20527

Ejemplares similares